Lymphocyte Sub-populations and Auto Immune Diseases

To determine if artificial intelligence allow to detect lymphocyte subpopulations specific of diseases (such as primary Sjogren' syndrome and systemic lupus erythematosus) among patients with suspicion of autoimmune diseases.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Autoimmune Diseases Immune System Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU de Brest

Brest, 29609, France

About this study

The goal of this study is to determine if artificial intelligence allow to detect lymphocyte subpopulations specific of diseases (such as primary Sjogren' syndrome and systemic lupus erythematosus) among patients with suspicion of autoimmune diseases.

All patients who had an evaluation of their lymphocyte subpopulations between january 2010 and december 2016 will be included in a retrospective analysis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

autoimmune or infectious disease

Exclusion criteria

Treatment and study plan

Primary outcomes

Diagnosis of autoimmune disease

Time frame: an average of 1 year

Diagnosis (systemic lupus erythematosus, primary Sjopgren's ....) according to current ACR/EULAR criteria

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Lymphocyte Sub-populations and Auto Immune Diseases : What Type of Profile ? (SPLIT)

Acronym: SPLIT

Important dates

Study start: 2018
Primary completion: 2018
Study completion: 2018
First posted: Apr 3, 2019
Registry last updated: Apr 3, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed